TRIA Preps FDA Submission For OTC Skin Rejuvenating Laser, Files For IPO
This article was originally published in The Rose Sheet
Executive Summary
Aesthetic device maker plans to file a 510(k) this year with FDA for its over-the-counter, non-ablative laser to treat facial wrinkles, supported in part by proceeds from an initial public stock offering worth up to $86.3 million.
You may also be interested in...
In Brief
An updated draft of the Regulation for Safer Consumer Products, part of California’s Green Chemistry Initiative, is expected to release in June. More news in brief.
Energized Skin-Care Gizmos Making Waves In 2012
“Kinetique” or energy-based beauty, including anti-aging devices, will help define the global market in 2012, says research firm Mintel. With strong presence in U.S., aesthetic devices are gaining in popularity in EU.
TRIA Beauty Alleges Laser Hair-Removal Center Mislead Customers, Files Suit
Aesthetic device maker TRIA Beauty is bringing a lawsuit against Phoenix Rising Laser, which made "erroneous statements" about TRIA's at-home hair-removal system, according to its July 21 release